Navigation Links
Statins Can Help Prevent Second Stroke
Date:5/25/2009

New study strengthens prior research on the cholesterol-lowering drugs

MONDAY, May 25 (HealthDay News) -- Taking a cholesterol-lowering statin after a stroke reduces the risk of a second stroke, new research shows.

The 10-year study of nearly 800 people who had strokes found a 35 percent lower incidence of second strokes and a 57 percent lower death rate among those who took statins compared to those who didn't, according to a report in the May 26 issue of Neurology.

Statins include blockbuster medications such as Crestor, Lipitor, Pravachol and Zocor.

The new Greek study echoes findings from an even bigger international trial, reported in 2006, called Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL).

Together, "our study and the SPARCL study have clearly shown the benefits of statins," said Dr. Sotirios Giannopolous, assistant professor of neurology at the University of Ioannina, Greece, and lead author of the new trial.

SPARCL involved more than 4,700 individuals treated for strokes or "mini-strokes" (formally called transient ischemic attacks) at 205 medical centers around the world. It found a 16 percent reduction in second strokes, as well as a 35 percent reduction in major coronary events among participants given 80 milligrams a day of a single statin, Lipitor.

In the new Greek study, Giannopolous' team found that about 8 percent of those on statins had a second stroke, compared to 16 percent of participants not taking the medications.

The new study rounded out the SPARCL results because "we have included all statins in all dosages, thus our study reveals the drug class effect," Giannopoulos said. Based on the findings, "I would recommend administration of a statin on admission to a hospital," he said.

But Giannopoulos stressed that the cholesterol-lowering activity of a statin may not be the prime cause of related reductions in stroke. "Statins have anti-inflammatory and antioxidative effects," he said, "and [they] also prevent blood clotting and stabilize plaque in the arteries. So, one of these mechanisms may help to prevent recurrent stroke."

Reports that statins can help prevent stroke recurrence are already affecting medical practice, he said. "It is almost policy here in the United States to start statin therapy after stroke, even in patients with normal cholesterol levels," Giannopoulos said.

That is true to some extent, added Dr. Gary Abrams, an associate professor of neurology at the University of California, San Francisco.

Statins are "regularly used, certainly, by stroke experts," Abrams said. "It is unclear how well it is permeating the general medical community, but as the evidence unfolds I believe use will be more widespread."

While the Greek study has "a lot of useful information, it has certain weaknesses," Abrams said. "It doesn't really provide information about which statin to use and it doesn't provide information about dosages."

But there's no clear evidence that one statin is better than another, anyway, Abrams said. "My belief is that probably any statin is better than none at all," he said. "In terms of dosage, you have to target that to certain lipid [cholesterol] levels. Which statin? That question is still open."

Abrams agreed that the exact mechanism of action is unclear. "It depends partly on lipid-lowering, partly from reducing inflammation and partly from the direct effect on blood vessels," he theorized.

More information

There's more on stroke treatment at the American Heart Association.



SOURCES: Sotirios Giannopoulos, M.D., assistant professor, neurology, University of Ioannina, Greece; Gary Abrams, M.D., associate professor, neurology, University of California, San Francisco; May 26, 2009, Neurology


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Statins alter prostate cancer patients PSA levels
2. Statins Guard Against Prostate Cancer
3. Statins may exert influence on prostate cancer growth by reducing inflammation
4. Many Who Should Use Statins Dont
5. Statins May Help Before Artery-Opening Surgery
6. Study Finds Millions More May Benefit From Statins
7. 6.5 million more patients might benefit from statins to prevent heart attacks, strokes
8. Statins lower stroke severity, improve recovery
9. Dallas Scientists Discover Statins May Falsely Indicate Thyroid Problems
10. Statins Pay Off on a Health-Policy Level, UCSF Study Finds
11. Not Many U.S. Kids Need Statins
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Statins Can Help Prevent Second Stroke
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... -- Story Highlights: , ... health care industry is causing providers to review operating ... offers a suite of solutions for health care providers ... optimization: labor resource analysis, revenue cycle optimization and physician ... and better economics ...
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
Breaking Medicine Technology: